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poptosis depends critically on regulated cytoskeletal
reorganization events in a cell. We demonstrate that
death effector domain containing DNA binding
protein (DEDD), a highly conserved and ubiquitous death
effector domain containing protein, exists predominantly as
mono- or diubiquitinated, and that diubiquitinated DEDD
interacts with both the K8/18 intermediate ﬁlament network
and pro–caspase-3. Early in apoptosis, both cytosolic
DEDD and its close homologue DEDD2 formed ﬁlaments
that colocalized with and depended on K8/18 and active
caspase-3. Subsequently, these ﬁlamentous structures col-
lapsed into intracellular inclusions that migrated into
cytoplasmic blebs and contained DEDD, DEDD2, active
A
 
caspase-3, and caspase-3–cleaved K18 late in apoptosis.
Biochemical studies further conﬁrmed that DEDD coimmu-
noprecipitated with both K18 and pro–caspase-3, and kinetic
analyses placed apoptotic DEDD staining prior to caspase-3
activation and K18 cleavage. In addition, both caspase-3
activation and K18 cleavage was inhibited by expression of
DEDD
 
 
 
NLS1-3, a cytosolic form of DEDD that cannot be
ubiquitinated. Finally, siRNA mediated DEDD knockdown
cells exhibited inhibition of staurosporine-induced DNA
degradation. Our data suggest that DEDD represents a
novel scaffold protein that directs the effector caspase-3
to certain substrates facilitating their ordered degradation
during apoptosis.
 
Introduction
 
Apoptosis is a fundamental cell elimination process central
to homeostasis regulation in all tissues. Dysregulation of
apoptosis can result in many pathological processes such as
degenerative diseases and cancer (Peter et al., 1997). Cells
undergoing apoptosis show a sequence of cardinal mor-
phological features including membrane blebbing, cellular
shrinkage, and condensation and fragmentation of the nuclei
(Wyllie et al., 1980; Earnshaw, 1995), most of which depend
on activation of caspases (Earnshaw et al., 1999; Stegh and
Peter, 2001). In epithelial cells, caspase-3, -6, and -7 are
involved in the cleavage of intermediate filament (IF)* proteins
such as cytokeratins, which is an important step during the
disintegration of cells (Caulin et al., 1997; Ku et al., 1997,
2002). However, little is known about the mechanisms that
ensure the ordered disintegration of cytoplasmic caspase
substrates.
We recently identified a protein that we called death effector
domain containing DNA binding protein (DEDD). Among
apoptosis signaling molecules, DEDD is unique, both in its
abundance and its conservation between species, indicating
an essential involvement in an evolutionarily universal process
(Stegh et al., 1998). DEDD contains three nuclear localization
signals and binds DNA and chromatin with high affinity
but predominantly resides in the cytoplasm, suggesting that
DEDD functions as a communicator between the cytoplasm
and nucleus (Stegh et al., 1998; Schickling et al., 2001).
Similar to several other DED proteins, overexpression experi-
ments suggested that DEDD was a proapoptotic molecule.
In contrast to all other DED proteins, DEDD requires nuclear
localization to induce apoptosis, suggesting that it engages a
novel nuclear apoptosis pathway (Schickling et al., 2001). In
the nucleoli, it activates and colocalizes with active caspase-6
and interacts with a novel DED binding protein DEDAF
(Zheng et al., 2001). 
We now show that in many cells cytosolic DEDD is ex-
pressed mostly in a diubiquitinated form which associates
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with both keratin 18 and procaspase-3. Upon induction of
apoptosis, cytosolic DEDD first aggregates and then stains in
filamentous structures associated with the cytokeratin 8/18
network in a strictly caspase-3–dependent fashion. We also
report the cloning of a close homologue of DEDD, which
was recently reported as DEDD2 (Roth et al., 2002) or
FLAME3 (Zhan et al., 2002). Using an antibody against the
DED of DEDD2, we demonstrate that DEDD2 can also be
stained on IFs in apoptosing cells. As apoptosis progresses,
K18 is cleaved by caspase-3 and reorganizes into intracellular
inclusions that colocalize with DEDD, DEDD2, and active
caspase-3. Expression of a cytosolic dominant negative ver-
sion of DEDD inhibits activation of caspase-3 and the subse-
quent cleavage of K18. Therefore, we conclude that DEDD
is important for the degradation of the IF system by caspase-3
and execution of apoptosis in epithelial cells. 
 
Results
 
DEDD forms ﬁlamentous aggregates 
in apoptosing cells
 
During immunofluorescence microscopy of untreated HeLa
cells, DEDD was detected using the DED3 antibody in nu-
cleoli (Fig. 1 A) but virtually undetectable in the cytoplasm.
However, 1 h after induction of apoptosis with staurosporine
(STS), DEDD stained as filamentous aggregates that seemed
to originate from a perinuclear structure. After 2 h, these fila-
mentous structures expanded to fill the entire cytosol of apop-
totic cells. In the final stage of apoptosis, coinciding with nu-
clear fragmentation, these DEDD filaments disintegrated
into bright inclusions (4 h of STS treatment). Specificity
of DEDD staining was confirmed by competition with the
DED3 peptide (Fig. 1 B). These data suggested that the
DED3-specific epitope in the native conformation of DEDD
becomes available in cells undergoing apoptosis. During the
course of apoptosis, nucleolar DEDD staining was progres-
sively reduced until undetectable at late stages. This phenom-
enon appeared to be independent of nucleolar segregation, as
evidenced by the persistence of nucleolar structures in phase
contrast even after the loss of nucleolar DEDD staining (2 h
postinduction, Fig. 1 A, arrowhead). These data suggested
that during apoptosis, nucleolar DEDD either leaves nucleoli
or changes its conformation so that it cannot be detected by
DED3. It is unlikely that DEDD is degraded by caspases be-
cause we have not found it to be a caspase substrate at these
time points (unpublished data). We conclude that cytosolic
DEDD either associates with or forms cytoplasmic filaments
in an apoptosis dependent manner.
 
Formation of filamentous DEDD structures 
requires caspase-3
 
Apoptosis induction was required to detect DEDD in fila-
mentous structures. This prompted us to test whether cas-
pases regulated DEDD filament formation. We first treated
HeLa cells with STS for 2 h in the absence and presence of
the poly-caspase inhibitor zVAD-fmk and found significant
inhibition of cytosolic DEDD filaments by zVAD-fmk (un-
published data). These data suggested that caspases played a
role in regulating the formation of DEDD aggregates. To de-
termine the contribution of the main effector caspase-3 to
this process, we tested MCF7 cells which do not express cas-
pase-3 (Janicke et al., 1998b) and compared them to cells re-
Figure 1. DEDD aggregates and forms filaments in apoptotic cells. (A) HeLa cells treated with 1  M STS for 0, 1, 2, or 4 h and stained with 
an anti-DEDD antibody (DED3) demonstrates both a dramatic differential subcellular localization of DEDD and an increase in the intensity of 
DEDD staining after the initiation of apoptosis. The low level of cytoplasmic staining detected in unstimulated cells was also found with control 
rabbit IgG (not depicted). Nuclei were visualized using DAPI (2  g/ml). Arrowheads denote nucleoli. (B) HeLa cells were treated as in (A) and 
stained with DED3 in the presence of the DED3-peptide (pep) leading to a competition for the binding sites of the antibody. Bar, 10  m. 
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constituted with procaspase-3 (MCF7-C3). In both MCF7-
vec and MCF7-C3 cells, DEDD was only detectable in nu-
cleoli prior to induction of apoptosis (Fig. 2 A). After treat-
ment of MCF7-vec cells with STS for 2 h, DEDD continued
to be detected exclusively in nucleoli, which started to segre-
gate. 4 h after treatment most DEDD reactivity had dimin-
ished (Fig. 2 A). The cells eventually detached and under-
went apoptosis (as judged by nuclear condensation;
unpublished data) without the detection of DEDD fila-
ments. In contrast, MCF7-C3 cells displayed both a change
in DEDD compartmentalization as well as highly ordered
structures during apoptosis. After 2 h of STS treatment,
DEDD filaments were detected surrounding the nucleus. Af-
ter 4 h of STS treatment massive amounts of DEDD fila-
ments formed in these cells (Fig. 2 A). At later stages, the fila-
ments appeared to fall apart leaving behind brightly stained
DEDD-positive inclusions (Fig. 2 A, arrowhead). These ex-
periments demonstrated that detection of DEDD in filamen-
tous structures requires active caspase-3. Fig. 2 B supports
this strict dependence on caspase-3. The majority of the
MCF7-C3 but none of the MCF7-vec cells became positive
when stained with the DED3 antibody. This experiment also
demonstrated that cells containing elongated DEDD fila-
ments showed no signs of nuclear changes such as conden-
sation and nuclear fragmentation (Fig. 2 B, arrowheads).
However, all cells with disintegrated DEDD filaments and
DEDD-positive inclusions exhibited such nuclear changes,
suggesting that formation of DEDD filaments precedes nu-
clear disintegration. During apoptosis, DEDD undergoes a
caspase-3–dependent change which exposes the epitope in
the DED recognized by DED3.
To determine the generality of DEDD filament forma-
tion, we quantified the increase of caspase-3–dependent
DEDD staining using different forms of apoptosis induc-
tion and established a FACS-based assay in permeabilized
cells (Fig. 2 C). All apoptosis stimuli tested (STS, etoposide,
UV, and TNF
 
 
 
) resulted in a clear increase in intracellular
DEDD staining, again only in the MCF7 cells reconstituted
with procaspase-3. In all cases we also detected DEDD in
filamentous structures (unpublished data). Thus, this behav-
ior of DEDD is a general phenomenon that can be observed
whenever caspase-3 is activated.
 
DEDD is a mono- and diubiquitinated protein
 
Two different anti-DEDD antibodies, PRO29 and DED3,
detected three protein forms of DEDD at 54, 44, and the
Figure 2. Filamentous DEDD requires 
caspase-3 and precedes nuclear 
changes in apoptosis. (A) MCF7-vec and 
MCF7-C3 cells were treated with 1  M 
STS for 0, 2, and 4 h and stained with 
DED3. Arrowhead denotes a strong 
DEDD-positive structure in a cell at a 
late stage of apoptosis. (B) MCF7-vec 
and MCF7-C3 cells were incubated for
4 h with 1  M STS and stained with 
DED3. Arrowheads in the MCF7-C3 
panels indicate cells that contain large 
amounts of DEDD filaments but lack 
apoptotic nuclear changes. Bar, 10  m. 
(C) Apoptosis-induced increase in 
DEDD staining was quantified via an 
intracellular FACS-based analysis in 
MCF7-vec (vec) and MCF7-C3 (C3) cells 
treated with a variety of apoptotic stimuli. 
Co, untreated control; Eto, etoposide; 
STS, staurosporine; TNF, tumor necrosis 
factor  ; UV, UV irradiation. 
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expected 37 kD (Fig. 3, A and B; unpublished data). These
three bands were spaced by 
 
 
 
8 kD, suggesting a covalent
modification of 8 kD, the size of ubiquitin. Therefore, we
tested whether the higher DEDD bands corresponded to
mono and diubiquitinated DEDD. This analysis was com-
plicated by the fact that the higher forms of DEDD cannot
be directly immunoprecipitated from cellular lysates due to
their insolubility (unpublished data). To test whether higher
DEDD bands could be detected upon overexpression of
DEDD, we transiently transfected 3
 
 
 
FLAG-tagged DEDD
(DEDD-FLAG) into 293T cells. Transfection of DEDD-
FLAG resulted in a weakly reactive 55-kD band (Fig. 3 D,
lane 4, bottom). Upon longer exposure of the same immu-
noblot, a faster migrating band at 45 kD was also detected
(Fig. 3 D, lane 4, top). These two FLAG reactive bands
likely represented the FLAG-tagged versions of the endoge-
nous 54- and 44-kD bands. Cotransfection of the same
amounts of DEDD-FLAG in the presence of HA-tagged
ubiquitin (Fig. 3 D, lanes 6–8) resulted in a much more effi-
cient formation of FLAG-reactive bands migrating above
DEDD-FLAG (Fig. 3 D, lane 8). The detected band mi-
grated 
 
 
 
4 kD slower than the highest band in cells trans-
fected with DEDD-FLAG, consistent with DEDD-FLAG
modified by two HA-ubiquitin (10 kD) rather than two en-
dogenous ubiquitin (8 kD) peptides. These data strongly
suggested that DEDD was a diubiquitinated protein. We
also detected higher molecular weight forms of DEDD
likely corresponding to higher order ubiquitinated DEDD
(Fig. 3 D, lane 8, top, arrowheads). To confirm the for-
mation of monoubiquitinated DEDD in 293T cells, we
cotransfected cells with DEDD-FLAG and HA-ubiquitin
and immunoprecipitated DEDD with anti-FLAG (Fig. 3
Figure 3. DEDD is mono- and 
diubiquitinated. (A) Western blot analysis 
of endogenous DEDD detected with the 
PRO29 antibody in total cellular lysates 
of Jurkat (J), HeLa (H), and MCF7 (M) 
cells. a and b represent higher forms of 
DEDD at 44 and 54 kD, respectively. 
(B) Both anti-DEDD antibodies, PRO29 
and DED3, detect band b in Western 
blots of the total cellular extracts of 
HeLa cells. (C) Schematic representation 
of the DEDD molecule. Sites of peptides 
used for the generation of the two rabbit 
polyclonal anti-DEDD antibodies DED3 
and PRO29 are indicated. (D) 293T cells 
were transfected with 12  g pcDNA3 
(vec), DEDD-FLAG (wt), or DEDD NLS 
( NLS) at the indicated amounts, in the 
absence (lanes 1–5) or presence (lanes 
6–9) of HA-ubiquitin and Western 
blotted with anti-FLAG. Short (bottom) 
and long (top) exposures are shown. 
Reprobe of blots with anti-HA yielded 
dark lanes in those cotransfected with 
HA-ubiquitin (not depicted). Arrow-
heads denote a higher species of DEDD 
after HA-ubiquitin cotransfection. (E) 
293T cells were transfected with vector 
(C), DEDD-FLAG (D), or DEDD-FLAG 
plus HA-ubiquitin (D   U). DEDD was 
immunoprecipitated with anti-FLAG 
(middle and right) and lysates (left) and 
precipitates were analyzed by Western 
blotting with either anti-FLAG (left and 
middle) or anti-HA (right). To better 
separate ubiquitinated DEDD from the 
IgG heavy chain (IgGH), conditions were 
chosen that resulted predominantly in 
formation of monoubiquitinated DEDD. 
(F) Temperature sensitive E1 mutant 
(ts20) and parental (E36) cell lines were 
cultured at the permissive temperature 
(30 C, lanes 1 and 3) and restrictive 
temperature (40 C, lanes 2 and 4) for 12 h and blotted with PRO29. Arrowhead denotes an unknown band found in both cell lines at the 
restrictive temperature. Additionally, deubiquitination of DEDD was also observed in 293T cells transfected with HA-ubiquitin and mock 
treated (lane 5) or treated with 20  M MG132 for 12 h (lane 6). (G) Proteins extracted from murine tissues were blotted with PRO29. Note 
that the blot shown represents one of four independent mice (two male, two female) bearing similar results. (H) Jurkat cells were treated with 
1  M STS for 10 h, lysed and separated into a detergent soluble (S) and an insoluble (P) fraction. DEDD was visualized by Western blotting 
using PRO29. DEDD
Ub, monoubiquitinated DEDD; DEDD
2Ub, diubiquitinated DEDD; DEDD
2HA-Ub, HA-tagged diubiquitinated DEDD. All Mr 
notations on left side of blots in kD. 
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E). A positive signal with anti-HA in Western blotting con-
firmed the identity of the 46-kD band as monoubiquiti-
nated DEDD (Fig. 3 E, right).
Conversely, to test whether endogenous DEDD was
mono- and/or diubiquitinated, we analyzed DEDD in a sys-
tem that lacked ubiquitination capabilities such as the ham-
ster cell line ts20 that expresses a temperature-sensitive mu-
tant of the ubiquitin-activating E1 enzyme (Zhande et al.,
2002). Because human DEDD is virtually identical to
mouse and rat DEDD, we expected our antibodies to detect
hamster DEDD. At the permissive temperature (30
 
 
 
C),
Western blot analysis revealed that these cells mainly express
the 44-kD DEDD species (Fig. 3 F, lane 1). However, after
inactivation of E1 at the restrictive temperature (40
 
 
 
C), a
significant amount of the 44-kD band disappeared which
paralleled with the appearance of 37 kD unmodified DEDD
(Fig. 3 F, lane 2). This effect was not seen in the control cell
line E36 (Fig. 3 F, lane 4), suggesting that the monoubiqui-
tinated DEDD was deubiquitinated in the absence of func-
tional E1. These data indicate that DEDD is mono- and di-
ubiquitinated. Interestingly, a recently described DEDD
mutant lacking all three NLS could not be significantly
ubiquitinated (Fig. 3 D, lane 9). This could be due to either
the deletion of the ubiquitinated lysine residue(s) that could
be part of the NLS or to the mutation of critical residues
that facilitate binding of the ubiquitinating enzymes. 
Unlike polyubiquitination, the role of monoubiquitina-
tion does not appear to be to target proteins to the protea-
Figure 4. DEDD associates with K18. 
(A) Apoptosis was induced in MCF7-C3 
cells (4 h, 1  M STS) and stained with 
DED3 and anti-K8 for confocal 
microscopy. Shown are two-dimensional 
pictures of three-dimensional images, 
which were created using 20 overlaying 
0.5  m z-sections. Merge panel is an 
overlay of the K8 and DEDD staining. 
Very significant colocalization was also 
seen on individual sections (not depicted). 
Bar, 10  m. (B) Electron microscopy of 
HeLa cells treated with TRAIL (2 h) 
detected DEDD and K18 in filamentous 
structures using immunogold labeling. 
Arrowhead denotes a characteristic 
K18 10-nm filament. Note that these 
filaments appear shorter than usual 
likely due to the onset of apoptosis. 
Bar, 200 nm. (C) Solubilization and 
immunoprecipitation of K18 in non-
apoptosing and apoptosing (treated with 
etoposide [Eto] for 16, 24, or 48 h) HeLa 
cells coimmunoprecipitated DEDD as 
detected by both DED3 and PRO29 
antibodies. 1C4, an anti-FADD antibody, 
was used as an IgG1 control immuno-
precipitation. IgGH, IgG heavy chain. 
Arrowhead denotes higher DEDD reactive 
band formed upon Eto treatment. All Mr 
notations on left side of blots in kD. 
(D) MCF7-C3 cells were treated with STS 
(1  M) for 8 h, fixed with paraformalde-
hyde, stained with DED3 and DAPI, and 
visualized by fluorescence microscopy. 
Arrowheads indicate DEDD-containing 
intracellular inclusions found in late stages 
of apoptosis after filament disintegration 
and coinciding with nuclear changes. 
Bar, 10  m. (E) A549 cells were treated 
with TRAIL (1  g/ml, 3 h) and subjected 
to immunoelectron microscopy. A typical 
intracellular inclusion found late in 
apoptosis is shown labeled by both 
DED3 (labeled with 10-nm gold particles) 
and anti-K18 (labeled with 5-nm gold 
particles). Bar, 200 nm. (F) DEDD 
filaments and intracellular inclusions 
(inset) in MCF7-C3 cells stained with 
anti-DEDD2 after apoptosis induction (1  M STS, 4 h). Bar, 10  m. Arrowhead, nucleus of nonapoptosing cell, which did not stain with 
anti-DEDD2. (G) Schematic representation of DEDD2. Site of the peptide used for the generation of the rabbit polyclonal anti-DEDD2 
antibody is indicated. 
1056 The Journal of Cell Biology 
 
|
 
 
 
Volume 158, Number 6, 2002
 
some-mediated degradative pathway. In fact, treatment of
cells with proteasome inhibitors has been reported to result
in deubiquitination of monoubiquitinated proteins such as
histone H2A and H2B (Mimnaugh et al., 1997) and the
HIV-1 p6
 
Gag
 
 protein (Schubert et al., 2000), likely due to
the depletion of cells of free ubiquitin which gets bound to
accumulating polyubiquitinated proteins. To test whether
diubiquitinated DEDD would also be deubiquitinated in
cells treated with proteasome inhibitors we transiently trans-
fected 293T cells with HA-ubiquitin (resulting in detection
of only diubiquitinated endogenous DEDD) and treated
with 20 
 
 
 
M of MG132 for 12 h (Fig. 3 F, lane 6). A com-
plete conversion of 55 kD DEDD into 37 kD DEDD was
detected, consistent with DEDD being deubiquitinated. To
confirm the existence of both the mono- and the diubiquiti-
nated DEDD species in primary cells, we tested expression
of DEDD in tissues of mice (Fig. 3 G). Kidney expresses
mainly unmodified DEDD, and tongue and lung contain
mainly mono- and diubiquitinated DEDD, respectively,
and colon and lung expressed mixtures of different DEDD
species. These data indicated tissue specificity in DEDD ex-
pression and ubiquitination. 
We noticed that ubiquitinated DEDD is less soluble than
unmodified DEDD (unpublished data) consistent with our
observation that DEDD-FLAG was more efficiently immu-
noprecipitated than HA-Ubi-DEDD-FLAG (Fig. 3 E). In-
duction of apoptosis in Jurkat T cells by STS coincided with
a disappearance of the 37-kD DEDD band in the deter-
gent soluble fraction and an appearance of diubiquitinated
DEDD in the detergent insoluble fraction (Fig. 3 H). This
change in solubility was recapitulated in fractionation of
HeLa cells (unpublished data). Further characterization of
these fractions identified cytoskeletal proteins, such as kera-
tin 8 (K8), specifically fractionated as detergent insoluble
corresponding to the low solubility of keratins in NP-40.
Thus, the newly formed DEDD
 
2Ub
 
 cofractionated with K8
in HeLa cells indicating that DEDD
 
2Ub
 
 possessed solubility
properties of cytoskeletal proteins. 
 
DEDD colocalizes and associates with cytokeratin 8/18
 
Apoptotic DEDD-positive filamentous structures strongly
resembled filamentous structures formed by cytoskeletal
proteins, suggesting that DEDD may interact with the cyto-
skeleton. To test this, we stained cells for DEDD, actin, mi-
crotubules, and cytokeratins. We did not detect a colocaliza-
tion of DEDD with either actin or microtubules
(unpublished data). However, DEDD appeared to colocal-
ize with cytokeratins in STS treated MCF7-caspase-3 cells
(Fig. 4 A). We chose to stain for cytokeratin 8 (K8), as it is
known that K8, compared with K18, is much more resistant
to caspase cleavage (Caulin et al., 1997; Ku et al., 1997). In-
terestingly, confocal microscopy indicated that not all IFs
stained positive for DEDD, but virtually all DEDD-positive
structures were stained with the K8 antibody. A similar re-
sult was obtained when cells were costained for DEDD and
K18 (unpublished data). A costaining of DEDD with K18
in IF structures was also observed in HeLa cells treated with
TRAIL for 2 h using electron microscopy and immunogold
labeling (Fig. 4 B). Because DEDD is only detectable in ap-
optosing cells by microscopy, these experiments did not ad-
dress whether DEDD was constantly associated with the IF
system with the DED3 epitope becoming accessible dur-
ing apoptosis or whether it associated with cytokeratins in
a stimulation dependent manner. To determine whether
DEDD was associated with K18 in nonapoptosing cells, we
performed an immunoprecipitation experiment using an
anti-K18 antibody with the detergent Empigen BB, re-
ported to solubilize 
 
 
 
40% of cellular cytokeratins in simple
epithelial cell lines (Lowthert et al., 1995). In agreement
with our cell fractionation results, DEDD coimmunoprecip-
itated with full length K18 (Fig. 4 C). Specifically, the coim-
munoprecipitated band was DEDD
 
2Ub
 
 and could again be
detected with both anti-DEDD antibodies. When apoptosis
was induced by treating these cells with etoposide for 48 h,
K18 was completely degraded in these cells and conse-
quently DEDD could no longer be immunoprecipitated
with the anti-K18 antibody (Fig. 4 C, lane 8), suggesting
that in these cells, DEDD
 
2Ub
 
 stays bound to K18 through-
out the apoptosis induction. Interestingly, we detected the
appearance of higher forms of DEDD that could point to an
apoptosis induced ubiquitination of DEDD during this
treatment (Fig. 4 C, bottom, arrowhead). 
Late during apoptosis, the IF networks collapse and all cas-
pase-cleaved and disintegrated cytokeratins are found in intra-
cellular inclusions (MacFarlane et al., 2000). Like cyto-
keratins, DEDD was also detected in granular structures late
in apoptosis (Fig. 4 D) which could be observed in the phase
contrast as dark structures (unpublished data). Therefore,
we tested whether these DEDD-containing structures were
identical to the keratin-containing inclusions previously de-
scribed. Using different sized gold particles conjugated to sec-
ondary antibodies, we performed a costaining analysis using
electron microscopy (Fig. 4 E) on TRAIL-treated A549 cells.
DEDD completely colocalized with keratin 18 (Fig. 4 E) and
vimentin (unpublished data) in these structures, confirming
that the DEDD-positive granules detected in this work are
identical to the previously described inclusion bodies. We
performed this analysis using EM because it was previously
shown that the inclusions are filled with tightly packed amor-
phous protein such that the interior of the inclusion is impen-
etrable by antibodies in confocal microscopy, a phenomenon
also observed for DEDD (unpublished data). Interestingly,
when we used an antibody against the DED of DEDD2 to
stain STS-treated MCF7-C3 cells, we detected DEDD2 in
both IF like filamentous structures (Fig. 4 F) and, at later
stages of apoptosis, in the same inclusions as DEDD (Fig. 4
F, inset), suggesting that DEDD and DEDD2 act together.
 
DEDD partially colocalizes with caspase-3–cleaved K18
 
During apoptosis induced by various methods, many type I
keratins are cleaved by caspases (Oshima, 2002) resulting in
disintegration of the IF system. Two cleavage sites have been
identified in K18 (Fig. 5 A). Asp238, in the center of the
molecule is cleaved by both caspase-3/7 and caspase-6 and
Asp397, at the COOH terminus, is specific for caspase-3/7
cleavage. Cleavage at D397 occurs early during apoptosis
and generates a neoepitope reactive with the commercially
available antibody M30, that can be used to monitor cas-
pase-3 activation (Leers et al., 1999). Caspase-mediated
cleavage of K18 (48.1 kD) generates 45-, 26.3-, and 19-kD 
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fragments (Caulin et al., 1997; Ku et al., 1997). In both
MCF7-vec and MCF7-C3 cells, STS treatment generated
the 45 kD large fragment (D397 cleavage), which migrates
close to the full-length K18, demonstrating that caspase-3 is
not absolutely required for cleavage at D397 (Fig. 5 B, lanes
2, 4, 6, and 8). However, complete cleavage of K18 at both
D238 and D397 was markedly different between MCF7-vec
and MCF7-C3. STS treatment (8 h) of MCF7-C3 cells re-
sulted in a significant amount of K18 cleavage based on the
generation of the 26.3-kD fragment, identifying the epitope
of the anti-K18 mAb in the NH
 
2
 
-terminal half of the pro-
tein (Fig. 5 B, lane 4). Under the same conditions, the M30
Ab detected two fragments (45 and 19 kD), both of which
must contain the neoepitope formed after cleavage of K18 at
position D397 (Fig. 5 B, lane 8). The absence of both the
26.3- (Fig. 5 B, lane 2) and the 19-kD (Fig. 5 B, lane 6)
fragments in MCF7-vec cells indicates that the K18 cleavage
at D238 requires caspase-3. 
Because DEDD associated with cytokeratin 8/18, we
tested whether an association between caspase-3 (M30 posi-
tive)-cleaved K18 and DEDD could be established (Fig. 5
C). A confocal microscopic analysis showed that a small but
significant amount of DEDD colocalized with caspase-3–
cleaved K18 in the center, but not in the periphery of the
Figure 5. Caspase-3–dependent K18 cleavage products colocalize with apoptotic DEDD structures. (A) Scheme of the caspase-cleavage of 
K18. (B) Total cellular lysates of MCF7-vec and MCF7-C3 cells before and after induction of apoptosis (STS 1  M, 8 h) were blotted with 
anti-K18 and M30 to detect keratin cleavage. Sizes in kD correspond to fragment sizes in A. (C) Early apoptotic MCF7-C3 cells (treated with 
STS 1  M, 4 h) displayed colocalization of DEDD and cleaved K18 filaments in confocal microscopy as detected by DED3 and M30. Shown 
are 2D-pictures of 3D-images, which were created using 20 overlaying 0.5  m z-sections. Merge, overlay of the M30 and DEDD staining. 
Bar, 10  m. (D) Late apoptotic MCF7-C3 cells (200  M etoposide, 24 h) displayed colocalization of DEDD and cleaved K18 in intracellular 
inclusions in confocal microscopy as detected by DED3 and M30. Shown are two-dimensional pictures of three-dimensional images, which 
were created using 20 overlaying 0.5  m z-sections. Selected cytoplasmic blebs containing DEDD and caspase-3–cleaved K18 are labeled 
by arrowheads. Bar, 10  m. (E) A549 cells treated with TRAIL (1  g/ml) for 3 h were subjected to immunoelectron microscopy. Late apoptotic 
intracellular inclusions (Incl.) were found to contain both DEDD, detected by DED3 (10 nm gold particles), and cleaved K18, detected by 
M30 (5-nm gold particles). Bar, 400 nm. 
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cells (Fig. 5 C). At later stages of apoptosis, both caspase-3–
cleaved K18 and DEDD colocalized in the cytoplasmic in-
clusions (Fig. 5 D). Again, we detected some inclusions that
stained positive for cleaved K18 but negative for DEDD
(Fig. 5 C, arrowhead). Using EM, we confirmed that
DEDD colocalizes with cleaved K18 in these structures (Fig.
5 E) and, in the final stage of apoptosis, these inclusions mi-
grated into cytoplasmic blebs (Fig. 5 D; unpublished data). 
 
DEDD aggregation precedes activation of caspase-3 
and cleavage of K18
 
To determine the sequence of events involving DEDD
changes and K18 cleavage, and to determine whether the
ability of DEDD to stain IF like structures required the pres-
ence of cytokeratins, we compared the keratin deficient cell
line SW13 with SW13 cells stably expressing K8 and K18
(Fig. 6). In the SW13 cells that do not express keratins, in-
duction of apoptosis by STS resulted in detection of DEDD
in intracellular aggregates (Fig. 6 A, arrowhead). This result
indicated that the aggregation of DEDD is independent of
its association with cytokeratins. However, in the K8/K18-
expressing SW13 cells, DEDD stained in filaments that
again colocalized largely with K18 (Fig. 6 B; unpublished
data). To test whether the change of DEDD was generally
occurring in cells lacking IF proteins, we treated a number of
lymphoid cells with STS and stained for intracellular DEDD
in a FACS-based analysis (Fig. 6 C). In all cases, DEDD
staining increased during the course of apoptosis. The in-
crease in intracellular DEDD staining could be prevented by
pretreating cells with the poly-caspase inhibitor zVAD-fmk
as shown for HeLa cells (Fig. 6 D), again confirming that ac-
tive caspases were required for the increased staining of
DEDD. Taken together, all data indicated the change of
DEDD is independent of cytokeratins, suggesting that it pre-
cedes changes in the IF system during apoptosis, and that it
may regulate these changes. To test whether DEDD played a
regulatory role in the caspase-mediated cleavage of K18, we
compared the kinetics of the DEDD apoptotic staining with
activation of caspase-3 and cleavage of K18 by caspase-3 in
HeLa cells (Fig. 6 E). After 1 h of STS treatment we detected
few M30-positive cells by intracellular staining, whereas the
DED3 staining had already reached 
 
 
 
70% of its maximal re-
sponse. In this particular experiment, after 4 h of treatment,
almost all cells positive for DEDD also contained caspase-3–
cleaved K18. Comparison of these events with the appear-
ance of processed caspase-3 revealed that the kinetics of cas-
pase-3 activation in these cells were indistinguishable from
the kinetics of K18 cleavage, confirming that M30 staining
was effective in quantifying the activation of caspase-3. These
data were also confirmed by quantifying immunofluores-
cence data (unpublished data). The observation that the in-
crease in staining and aggregation of DEDD are both inde-
pendent of keratins and precedes activation of caspase-3 and
K18 cleavage by caspase-3 suggests that DEDD may func-
tion in facilitating caspase-3 cleavage of K18.
 
DEDD and active caspase-3 localize 
to intermediate filaments during apoptosis
 
Though the biochemical and immunofluorescence data sug-
gested a role for DEDD in mediating caspase-3 cleavage of
K18, DEDD filaments only partially overlapped with cas-
pase-3–cleaved K18 (Fig. 5 C). If DEDD is involved in the
recruitment and activation of caspase-3 one would expect
that active caspase-3 would primarily be associated with
DEDD and not with K18. To test this hypothesis we treated
MCF7-C3 cells with STS and stained with M30 and an an-
tibody specific for the neoepitope in caspase-3 that forms af-
ter processing of caspase-3 between its active subunits (Fig. 7
A). The result demonstrated that there was only a partial
colocalization of active caspase-3 with caspase-3–cleaved
Figure 6. Apoptosis-induced DEDD 
structures and aggregation are 
independent of keratins and occur before 
caspase-3 cleavage of K18. (A) Non-
apoptosing and apoptosing (STS 1  M, 
4 h) SW13 2C4 K  cells stained with 
DED3 and visualized in immuno-
fluorescence. The arrowhead denotes 
one of the brightly staining DEDD 
structures only found in apoptosing 
cells. (B) SW13 cells reconstituted with 
K8/K18 (2C6 K ) also reconstituted 
apoptotic DEDD filaments following STS 
treatment (1  M, 4 h). Bar, 10  m. 
(C) Lymphoid cell lines treated with 
STS for 0, 2, 4, and 8 h and stained for 
intracellular DEDD using DED3 and 
FACS analysis. (D) HeLa cells treated 
with STS (1  M) for 0, 2, 4, and 8 h in 
the absence or presence of pretreatment 
with zVAD-fmk (50  M, 30 min) and 
analyzed as in C. (E) HeLa cells treated 
with STS (1  M) for 0, 1, 2, 3, and 4 h 
and stained with DED3, M30, or anti-
active caspase-3.  
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K18 in the perinuclear area of the cells, a spatial relationship
reminiscent of DEDD and M30. We then directly costained
MCF7-C3 cells treated with STS for DEDD and active cas-
pase-3 (Fig. 7 B). In all cells, of which only one is shown, all
filamentous DEDD stained positive for active caspase-3,
suggesting that DEDD recruited caspase-3 to IFs. Upon
closer inspection of these stainings we detected small granu-
lar structures containing active caspase-3 which did not stain
for DEDD and that seemed to emanate from the filamen-
tous structures (Fig. 7 B, arrowheads).
Filaments formed by DEDD in apoptosing cells were
somewhat reminiscent of filaments that were shown to form
upon overexpression of certain DED proteins. It had been
shown that these “death effector filaments” colocalized with
and activated caspase-8 (Siegel et al., 1998). Therefore, we
stained STS-treated MCF7-C3 cells for DEDD and caspase-8
(unpublished data) but found no colocalization of DEDD
filaments with caspase-8, suggesting that DEDD specifically
colocalized with processed caspase-3.
To determine the association of processed caspase-3 and
DEDD during different stages of apoptosis, we performed an
EM analysis of HeLa cells treated with TRAIL. In early stages
of apoptosis, DEDD colocalized with active caspase-3 on IFs
(Fig. 7 C, left). At intermediate stages when IF filaments
started to disintegrate, DEDD colocalized with active caspase-3
on the remaining sheaves of IF structures (Fig. 7 C, middle,
arrowhead) and in small inclusions. At later stages, these small
inclusions fused to larger structures still containing DEDD
and active caspase-3 (Fig. 7 C, right). This analysis was sup-
ported by a kinetic analysis of STS-treated MCF7-C3 cells us-
ing immunofluorescence microscopy (unpublished data) and
demonstrated that the colocalization of caspase-3 subunits
with DEDD is not restricted to a cell line that stably expresses
exogenous procaspase-3 but can also be found between en-
dogenous DEDD and endogenous active caspase-3. These
data strongly suggested a direct interaction between DEDD
and caspase-3 that results in activation of caspase-3.
 
Caspase-3 is recruited to K8/K18 during apoptosis
 
Though procaspase-3 is evenly distributed in the cytosol in
most cells, active caspase-3 localizes with certain keratins to
intracellular inclusions in late stage apoptosing epithelial
Figure 7. DEDD colocalizes with 
active caspase-3 during apoptosis. 
(A) Apoptotic MCF7-C3 cells (1  M STS, 
4 h) costained with anti-active caspase-3 
and M30. Bar, 10  m. (B) Apoptotic 
MCF7-C3 cells (1  M STS, 4 h) costained 
with anti-active caspase-3–FITC and 
DED3. Bar, 10  m. Arrowheads denote 
small granules that were only positive for 
active caspase-3. (C) HeLa cells treated 
with TRAIL (1  g/ml, 2 h) were subjected 
to immunoelectron microscopy. DEDD 
(10-nm gold particles) and active, cas-
pase-3 (5-nm gold particles) were found 
to colocalize in filaments (early stages 
of apoptosis), small intracytoplasmic in-
clusions (intermediate stages of apopto-
sis), and in large coalesced 
intracytoplasmic inclusions (late stages 
of apoptosis). The arrowhead denotes a 
residual DEDD and active caspase-3–
positive filament. Bar, 250 nm.  
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cells (Caulin et al., 1997; MacFarlane et al., 2000). If kera-
tin-bound DEDD is involved in the caspase-3 cleavage of
keratins caspase-3 should be detectable at IFs. Due to the
lack of anti–caspase-3 antibodies for adequate procaspase-3
detection in immunofluorescence microscopy, we tran-
siently transfected MCF7 cells with a pro–caspase-3–GFP
fusion protein and induced apoptosis by treating cells with
STS. After fixation with paraformaldehyde cells were stained
with anti-K8 (Fig. 8 A). In untreated cells caspase-3–GFP
was detected throughout the cytosol with no significant
colocalization with K8 and expression of the fusion protein
did not affect the integrity of the IF system (Fig. 8 A, top
row). Late after induction of apoptosis at 4 h of STS treat-
ment both caspase-3–GFP and K8 were found in the same
intracellular inclusions (Fig. 8 A, bottom row) in agreement
with previous reports. However, at an earlier stage of apop-
tosis (2 h after STS treatment), caspase-3–GFP was found in
small structures lining IF filaments mostly in the center of
the cells (Fig. 8 A, middle row). The association of caspase-3
with K8 in early apoptosing cells was most evident in a
three-dimensional movie (Video 1, available at http://
www.jcb.org/cgi/content/full/jcb.200112124/DC1). To di-
rectly test whether DEDD associates with procaspase-3 prior
to induction of apoptosis we immunoprecipitated pro-
caspase-3 from MCF7-C3 cell lysates and immunoblotted
with biotinylated PRO29 (Fig. 8 B). The only DEDD-reac-
tive band that specifically associated with caspase-3 was the
54-kD band of DEDD. Because our analysis of this band
had identified it as diubiquitinated DEDD, we now re-
probed that blot with an anti-ubiquitin mAb and confirmed
that this protein is both reactive with anti-DEDD and
anti-ubiquitin antibodies. Our data suggested that pro-
caspase-3 in MCF7-C3 cells is associated with diubiquiti-
nated DEDD, and that DEDD mediates recruitment of
procaspase-3 to the IFs during apoptosis, leading to cleavage
of IF proteins such as K18 or vimentin.
 
DEDD is involved in activation of caspase-3, 
cleavage of K18, and execution of apoptosis
 
To directly determine the role of DEDD in apoptosis of ep-
ithelial cells, we made use of the RNAi technology to down-
regulate selected mRNAs (Elbashir et al., 2001). HeLa cells
were mock treated or treated with lamin A/C or DEDD-
specific siRNAs and tested for expression of lamin A/C and
DEDD proteins by Western blotting (Fig. 9 A). Treatment
of cells with the lamin A/C siRNA resulted in a strong re-
Figure 8. Caspase-3 is recruited to IFs 
and associates with DEDD. (A) MCF7 
cells were transiently transfected with 
procaspase-3–GFP, treated with STS (0, 2 
and 4 h) and stained for K8. Cells were 
analyzed by confocal microscopy. Shown 
are two-dimensional pictures of three-
dimensional images, which were created 
using 20 overlaying 0.5  m z-sections. 
Merge, overlay of GFP fluorescence 
and K8 staining. Arrowheads denote 
caspase-3–GFP positivity on IFs. A 
three-dimensional image of this panel is 
depicted in Video 1 (available online at 
http://www.jcb.org/cgi/content/full/
jcb.200112124/DC1). Bar, 10  m. 
(B) Immunoprecipitation of caspase-3 
from MCF7-C3 (with a rabbit polyclonal 
caspase-3 antibody) coimmuno-
precipitated DEDD
2Ub as detected by 
biotinylated PRO29 and anti-ubiquitin 
mAb (left two panels). Control blot (right) 
with a different caspase-3 (CASP-3) mAb 
detected efficient caspase-3 immuno-
precipitation. Note, the same blot was 
probed sequentially in the order PRO29, 
anti-CASP-3, anti-ubiquitin. All Mr 
notations on left side of blots in kD. 
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duction of lamin A/C expression but did not affect expres-
sion of DEDD
 
Ub
 
 or DEDD
 
2Ub
 
 (no unmodified DEDD was
detected in this experiment). Conversely, treatment of cells
with the DEDD siRNA did not alter expression of lamin A/
C, but resulted in a profound loss of both DEDD proteins.
Neither siRNA significantly decreased the amount of cas-
pase-8 which we used as a loading control. However, we re-
alized that both siRNAs were somewhat toxic for HeLa cells,
as we also detected the caspase-8 cleavage intermediates p43
and p41 (Medema et al., 1997) indicating that transfection
of cells with the siRNAs caused weak apoptosis which was
not observed in the mock transfected cells (Fig. 9 A, lane 1).
To test whether DEDD was important for execution of
apoptosis in HeLa cells, DNA fragmentation was quantified
in siRNA-transfected cells treated with STS for 4 h (Fig. 9
B). Three different concentrations of siRNA confirmed that
lamin A/C siRNA treated-cells were sensitive to STS in-
duced DNA fragmentation. However, at the same three
concentrations of DEDD, siRNA cells were resistant to
STS-induced DNA fragmentation but exhibited a higher
level of basal DNA fragmentation without apoptotic stimu-
lus when compared with cells transfected with lamin A/C or
luciferase siRNAs (unpublished data). This could be due to
dual functions of DEDD at its two intracellular locations,
the nucleus and the cytoplasm. Downregulation of DEDD
in nucleoli may reduce the cell viability before the effect of
the downregulation of DEDD in the cytosol could be seen.
Therefore, we sought a way to selectively modulate DEDD
in the cytosol.
Overexpression of a cystolic DEDD mutant with a dele-
tion of all three nuclear localization signals (DEDD
 
 
 
NLS)
does not induce apoptosis (Schickling et al. 2001). To test
whether DEDD NLS would interfere with the function of
endogenous DEDD in the cytosol, we utilized a fusion pro-
tein consisting of the extracellular and transmembrane do-
mains of CD8 linked to the caspase-8 enzymatic domains
(CD8:C8). This construct had been described to induce
apoptosis upon overexpression by specific activation of
caspase-8 through induced proximity facilitated by the con-
stitutively dimerizing Ig domains of CD8 (Martin et al.,
1998). Overexpression of CD8:C8 caused caspase-3 cleav-
age of K18 as detected by M30 staining of transfected cells
quantified by flow cytometry (Fig. 9 C). However, cotrans-
fection of increasing amounts of DEDD NLS with CD8:
C8 inhibited cleavage of K18 at position D397 to back-
ground levels. Coexpression of DEDD NLS did not affect
the amount of active caspase-8 (Fig. 9 C, right) generated by
CD8:C8 expression, suggesting that DEDD NLS acted by
specifically inhibiting the degradation of K18 by caspase-3.
The dominant negative effect of DEDD NLS suggests
that it could either bind to IF proteins, directly blocking ac-
cess of caspase-3 to K18, or it could prevent activation of
Figure 9. DEDD is important in epithelial cells for activation of caspase-3. (A) RNAi was performed in HeLa cells by transfection with 
lamin A/C or DEDD siRNA. Western blots were probed with anti-lamin A/C (top) and PRO29 (middle). Protein loading was determined by 
anti-caspase 8 (bottom). C, control (mock transfected); L, 10 nM lamin A/C siRNA; D, 10 nM DEDD siRNA. All Mr notations on left side of 
blots in kD. (B) DNA fragmentation was assessed in HeLa cells treated with 5, 10, and 20 nM lamin A/C or DEDD siRNA in comparison to 
control (transfection reagent only). As quantified by a Cy3-conjugated luciferase siRNA, uptake of siRNA at the above concentrations was 
 90% (not depicted). (C) Transient transfection of 293T cells with 1  g of a CD8-caspase-8 fusion (CD8:C8) and increasing amounts of 
dominant negative DEDD (DEDD NLS). FACS analysis of M30 intracellular staining detected a decrease in fluorescence that correlated with 
increasing DEDD NLS dosage. Equal activation of caspase-8 was confirmed by a fluorogenic caspase assay with the IETD-AFC substrate. 
V, vector. (D) HeLa cells transfected with DEDD NLS, CD8:C8, or both indicated a reduction in caspase-3 activation as well as K18 cleavage in 
the presence of dominant negative DEDD. Cells were stained with anti-CD8 and M30 for FACS analysis. Caspase-8 and -3 activities were 
measured by a fluorogenic caspase assay with the IETD-AFC and DEVD-AFC substrates, respectively. 1062 The Journal of Cell Biology | Volume 158, Number 6, 2002
caspase-3 in the cytosol. To test whether cleavage of K18 by
caspase-3 was inhibited by DEDD NLS we transiently
transfected HeLa cells with the CD8:C8 construct with
DEDD NLS (Fig. 9 D). Expression of the CD8:C8 con-
struct was monitored by staining for surface CD8 by flow
cytometry. Again, coexpression of DEDD NLS did not af-
fect expression of CD8:C8 or the amount of caspase-8 gen-
erated in these cells (Fig. 9 D). As in 293T cells, DEDD -
NLS inhibited cleavage of K18 by caspase-3 and prevented
the appearance of caspase-3 like activity in the cytosol.
These data strongly argue that DEDD NLS does not sim-
ply block K18 cleavage by binding to K18, thereby blocking
access of caspase-3 to K18 but rather that DEDD NLS
regulates activation or activity of caspase-3 in the cytosol.
This argument is further supported by transient expression
of DEDD NLS–GFP fusion proteins in MCF7-C3 cells
which showed a diffuse cytosolic localization with no co-
staining with the IF system (unpublished data). Our experi-
ments in Fig. 3 have demonstrated that DEDD NLS can-
not be ubiquitinated. Therefore, the dominant negative
effect of DEDD NLS may be due to its inability to move to
the nucleus and/or its inability to be ubiquitinated, suggest-
ing that ubiquitination may serve as an important functional
regulator of DEDD. Taken together the data strongly point
to DEDD as a regulator of the cleavage of K18 by caspase-3
and suggest that DEDD is involved in activation of caspase-3
which leads to DNA fragmentation in the tested cells. 
Discussion
The apoptosis pathway is a chain of biochemical events that
affects all parts of the cell resulting in its ordered disintegra-
tion. Today,  120 dedicated apoptosis signaling proteins
are known that facilitate and regulate this process. Many of
these proteins carry specialized protein–protein interaction
domains such as the DED that ensure the ordered activation
of the main executioner in apoptosis, the caspases. Caspase-3
is the main effector caspase and consequently most of the
known caspase substrates have been shown to be cleaved by
caspase-3 most often at the expected DXXD cleavage site.
Currently there are  34,000 protein sequences in the NCBI
data base which contain 40,000 putative DXXD motifs that
could represent caspase-3 cleavage sites. However, only a rel-
atively small number of  100 caspase-3 substrates are
known (Tan and Wang, 1998; Earnshaw et al., 1999). Cas-
pases can be expressed in many intracellular compartments
(Stegh and Peter, 2001) and all caspases have been shown to
also be expressed in the biggest compartment, the cytosol.
The question of how specificity of substrate cleavage is
achieved in this compartment is only beginning to be eluci-
dated. In other signaling pathways this is often achieved by
utilizing scaffold proteins, adaptors that serve as platforms
on which specific signaling complexes are formed. Examples
for such proteins are SLP-76 for T cell receptor signaling
(Pivniouk et al., 1998) or JIP for MAP kinase signaling (Ya-
suda et al., 1999). We postulate that DEDD represents such
a protein in the apoptosis pathway. This conclusion is based
on the following observations: (a) DEDD interacts with
both procaspase-3 and its main substrate in epithelial cells,
keratin 18; (b) upon overexpression DEDD localizes to nu-
cleoli and colocalizes with active caspase-6 (Schickling et al.,
2001); (c) active caspase-3 almost exclusively colocalizes
with DEDD on IFs; (d) overexpression of a dominant nega-
tive mutant of DEDD inhibits activation of caspase-3; and
(e) downregulation of DEDD using DEDD-specific siRNA
inhibits STS-induced activation of caspase-3 (unpublished
data) and DNA fragmentation.
DEDD2 has a similar structure to DEDD (Roth et al.,
2002; Zhan et al., 2002; and this work). Like DEDD,
DEDD2 localizes to nucleoli when overexpressed and acts
proapoptotically from within the nucleus. Our experiments
detecting endogenous proteins demonstrated that an anti-
body against the DED in DEDD2 showed the same remark-
able staining as the DED3 antibody against the DED in
DEDD. In both cases, the increase in staining and detection
of brightly stained filamentous structures depended on acti-
vation of caspase-3. This strongly suggests that both proteins
act together and may even respond to the same stimuli. 
Due to its dual localization, DEDD may have different
functions in the nucleus and the cytoplasm. We have shown
that overexpression of DEDD in the nucleus affects DNA
Pol I-dependent transcription of rDNA (Stegh et al., 1998;
Schickling et al., 2001). Consistent with a nuclear function
of DEDD, it was recently reported that DEDD (and
DEDD2) interact with the TFIIIC102 subunit of the hu-
man transcription factor IIIC (Zhan et al., 2002). This find-
ing together with our recent identification of endogenous
DEDD as being in part a nucleolar protein (Schickling et
al., 2001) suggests that DEDD plays a role in the general
transcription machinery in the nucleus. This might explain
why downregulation of total cellular DEDD in HeLa and
MCF7 cells using DEDD-specific siRNA was more toxic to
the cells than treatment with control siRNAs. However, the
lack of induced DNA fragmentation after STS treatment
suggests that DEDD is required for STS induced apoptosis.
We conclude that this reflects DEDD’s cytoplasmic func-
tion since overexpression of purely cytosolic DEDD NLS
inhibited caspase-3 activation and cleavage of K18 in cells
cotransfected with the caspase-8 activating killer construct
CD8:caspase-8 (Martin et al., 1998). This activity of
DEDD NLS could be due to two functional changes when
compared to wild-type DEDD: the inability of the mutant pro-
tein to enter the nucleus or the lack of monoubiquitination.
The most well-known function of ubiquitination is to tar-
get proteins for degradation by the proteasome. However,
monoubiquitination has been shown to be involved in
endocytosis of a number of cellular and viral proteins (for
review see Hicke, 2001). The best-known monoubiquiti-
nated proteins are histones (Busch and Goldknopf, 1981).
Monoubiquitination of H2A and H2B has been shown to
be involved in gene regulation (Spencer and Davie, 1999).
However, only a fraction of histones are monoubiquiti-
nated. In contrast, DEDD represents the most quantitatively
monoubiquitinated protein known. Cleavage of diubiquiti-
nated DEDD with cyanogen bromide revealed that two dif-
ferent fragments are modified (unpublished data), indicating
that DEDD is monoubiquitinated at two different sites. In-
terestingly, it is diubiquitinated DEDD that coimmunopre-
cipitated with K18 or procaspase-3. We are currently test-
ing whether monoubiquitination of DEDD is required forDEDD regulates caspase cleavage of cytokeratins | Lee et al. 1063
these interactions to occur. Interestingly, no ubiquitinated
DEDD could be detected in nucleoli-enriched fractions
(Schickling et al., 2001; unpublished data), whereas in the
cytosol of the same cells DEDD was mainly ubiquitinated.
Therefore, mono- and diubiquitination could also regulate
DEDD’s intracellular localization.
Disintegration of the IF network is a general feature of
apoptosing cells and cleavage of IF proteins is important for
progression of apoptosis. Recent data indicate that IF pro-
teins play a dynamic role during apoptosis by actively regu-
lating the apoptotic process both positively and negatively.
Vimentin is cleaved by caspases during apoptosis (Prasad et
al., 1998; Morishima, 1999), generating a proapoptotic
NH2-terminal fragment (Byun et al., 2001). Cytokeratins 8
(K8) and 18 (K18), IF proteins present in primary and
transformed simple epithelia, seem to negatively regulate
the apoptosis sensitivity of certain cells such that K8 or K18
deficient epithelial cells are 100 times more sensitive to
TNF than wild-type cells (Caulin et al., 2000). The moder-
ation of TNF-induced apoptosis by K18 may be due to
competition between K18 and TNF-RI for TRADD, a key
TNF-RI adaptor protein (Inada et al., 2001). Another
study reported that the lack of cytokeratins strongly sensi-
tized hepatocytes to CD95 mediated apoptosis by allowing
CD95 to be transported more efficiently to the cell surface
(Gilbert et al., 2001). Many of the IF proteins contain con-
served cleavage sites for caspase-3 or -7 (at the COOH ter-
minus and in the center of the proteins) and for caspase-6
(in the center) (Caulin et al., 1997; Ku et al., 1997). Once
IF filaments have collapsed after cleavage by caspases, many
of the IF proteins can be found in specific intracellular in-
clusions (Caulin et al., 1997; MacFarlane et al., 2000).
These spheroidal inclusions contain K8, cleaved K18,
cleaved K19 but not K13/15/16, vimentin, and  -actin or
tubulin (Caulin et al., 1997; MacFarlane et al., 2000). In-
terestingly, not only cleaved cytokeratins but also most, if
not all, of the cytosolic pool of active caspase-3 were found
sequestered in these structures during TRAIL induced apop-
tosis in MCF7 cells (MacFarlane et al., 2000). We now
show that these inclusions which occur during a number of
other apoptotic stimuli that activate caspase-3 contain both
DEDD and DEDD2.
Detection of filamentous structures of active caspase-3 on
IF branches precedes the formation of these inclusions,
which also precisely colocalize with activated DEDD and
DEDD2. Because DEDD is constitutively associated with
K18 in nonapoptosing cells, DEDD likely changes its con-
formation while bound to K18. This conclusion is further
supported by the finding that in keratin-free SW13 cells
DEDD can be found in intracellular aggregates and not in
K8/18-like filamentous structures. Reconstitution of SW13
cells with both K8 and K18 resulted in detection of DEDD
filaments. We could detect no DEDD structures bound to
vimentin in a vimentin expressing variant of SW13 cells (un-
published data), suggesting that binding of DEDD to the IF
system is predominantly mediated through cytokeratins. 
DEDD was found to be associated with K18 and signifi-
cantly colocalized with K18 during immunofluorescence
microscopy. DEDD almost completely colocalized with ac-
tive caspase-3. Unexpectedly, colocalization of DEDD with
caspase-3–cleaved K18 was only partial. However, consis-
tent with DEDD’s localization, active caspase-3 also only
partially colocalized with caspase-3–cleaved K18. This find-
ing could be explained by the properties of the IF system
which has been shown to be highly dynamic (Prahlad et al.,
1998; Windoffer and Leube, 1999). We propose that ker-
atins after the initial caspase cleavage move away from cas-
pase-3/DEDD complexes, explaining the apparent dissocia-
tion of active caspase-3/DEDD with cleaved K18. At the
end stage of apoptosis when most inclusions have fused to
larger structures DEDD, cleaved K18 and active caspase-3
again colocalize in most of these inclusions.
Several models may explain the function of the DEDD
containing inclusions. It has been suggested that these inclu-
sions could be the final graveyard for active caspases such as
caspase-3, -7, and -9 (unpublished data). In this model, they
would represent structures used to inactivate and dispose of
active caspases. However, why only simple epithelial cells
and not numerous other cell types would use this mecha-
nism to dispose of caspases remains to be elucidated. It is
more likely that these structures serve a specific function.
Late during etoposide- and UV-induced apoptosis, most of
these structures were found in cytoplasmic blebs which
seemed to develop into apoptotic bodies (Fig. 5 D; unpub-
lished data). This effect was not seen in STS treated cells, as
STS has been shown to inhibit blebbing (Mills et al., 1998). 
Based on the new findings in this work, we have devel-
oped a model of DEDD’s function (Fig. 10). DEDD re-
sides in the cytoplasm in an inactive form bound to a popu-
lation of K18. Upon induction of apoptosis, a small
amount of caspase-3 is activated (step I), causing a confor-
mational change in DEDD (step II). This may attract and
activate more caspase-3 (step III), which then leads to cleav-
age of DEDD-associated cytokeratins (step IV). This step is
clearly evident by the complete colocalization of active cas-
pase-3, DEDD, and K18. After cleavage of K18, the IF net-
work collapses and DEDD, active caspases, and cleaved cy-
tokeratins are found in intracellular inclusions which may
subsequently migrate into cytoplasmic blebs (step V). Our
data indicate that activation of caspase-3 is both upstream
and downstream of DEDD. Caspase-3 activity is required
both for the conformational change of DEDD as well as
the cleavage of DEDD-associated IF proteins. Therefore,
DEDD would provide a unique way for one effector cas-
pase to be activated in two steps in the same compartment.
According to our model, DEDD could act as an intracellu-
lar timer to ensure degradation of substrates by caspase-3 in
an ordered fashion. The regulation of these two steps re-
quires further study.
We recently demonstrated that when it is overexpressed,
DEDD activates and colocalizes with active caspase-6 in nu-
cleoli (Schickling et al., 2001). We now report that en-
dogenous DEDD colocalizes with active caspase-3 on IFs.
Caspase-6 and -3 are the major caspases required for
disintegration of IF proteins (nuclear lamins and cytoker-
atins, respectively) which has been demonstrated to be an es-
sential step in the morphological changes seen during apop-
tosis (Rao et al., 1996; Caulin et al., 1997; Ku et al., 1997).
Future experiments will determine the exact mechanism
how DEDD and DEDD2 regulate theses processes.1064 The Journal of Cell Biology | Volume 158, Number 6, 2002
Materials and methods
Cell lines and reagents
HeLa, MCF7, Jurkat, H9, CEM, and BJAB cells were maintained in RPMI;
SW13, A549, and 293T cells were maintained in DME in a humidified at-
mosphere (5% CO2) at 37 C supplemented with L-glutamine, 100  g/ml
penicillin and streptomycin, and 10% heat-inactivated fetal calf serum
(Sigma-Aldrich). ts20 and E36 cells were provided by X.J. Sun (University of
Vermont, Burlington, VT) and maintained as previously described (Zhande
et al., 2002). MCF7 stable transfectants (vector and caspase-3) (Janicke et
al., 1998a) were supplemented with 100  g/ml G418 and SW13 stable
transfectants (vector and K8/K18) were supplemented with 400  g/ml
G418. The plasmids pcDNA3-3 FLAG-DEDD and pcDNA3-3 DEDD-
FLAG NLS1-3 (for simplicity we refer to these constructs as DEDD-FLAG
and DEDD NLS) have been described previously (Stegh et al., 1998;
Schickling et al., 2001). pEGFP-N1-Caspase-3 (MacFarlane et al., 2000),
pCEFL-CD8:C8 (Martin et al., 1998), and pMT123 (HA-Ubi) (Treier et al.,
1994) were provided by M. MacFarlane (University of Leicester, Leicester,
UK), M. Lenardo (National Institutes of Health, Bethesda, MD), and C. Pick-
art (Johns Hopkins University, Baltimore, MD), respectively.
Cloning of DEDD2 and generation 
of polyclonal anti-DEDD2 antiserum
TBLASTN searches of the human expressed sequence tag data base using
the DEDD open reading frame identified a clone BE797255 from a small
cell lung carcinoma library that contained a sequence that was highly ho-
mologous to 80% of the DEDD open reading frame. Sequencing of this
clone which was obtained from the ATCC revealed an open reading frame
coding for a protein of 326 amino acids that was 48% identical to DEDD
(EMBL/GenBank/DDBJ accession no. for DEDD2 cloned in this work:
AY125488). We then generated an antibody to the corresponding region
within the DED (APGAAGGLARARSGLE) of DEDD2 which was used to
generate the anti-DEDD antibody DED3. Although the DED between
DEDD and DEDD2 are 47.5% identical the region of this 16–amino acid
peptide only shared 2 identical amino acids. Subsequent tests revealed
that the antibodies DED3 and anti-DEDD2 were specific for DEDD and
DEDD2, respectively.
Induction of apoptosis
Apoptosis induction in cells used in immunofluorescence and intracellular
FACS stainings was performed with the following conditions: 1  M stauro-
sporine (Sigma-Aldrich) for the indicated times, 1  g/ml TRAIL (MacFar-
lane et al., 2000) for the indicated times, 200  M etoposide (Sigma-
Aldrich) for 24 h, 1  g/ml cycloheximide plus 20 ng/ml TNF  for 12 h, or
UV irradiated (100 kJ) and cultivated for 24 h after irradiation before harvest-
ing. To block apoptosis, cells were pretreated for 30 min with 50  M
zVAD-fmk.
Western blot
Western blotting was performed as previously described (Schickling et al.,
2001) with the following antibodies: PRO29 (previously called anti-
DEDD1; Schickling et al., 2001) (1  g/ml), biotinylated PRO29 (1  g/ml),
DED3 (previously called anti-DEDD2; Schickling et al., 2001) (1  g/ml),
anti-K8 (1  g/ml; Sigma-Aldrich), anti-FADD (1  g/ml; Transduction Labo-
ratories), anti-FLAG (1  g/ml; Sigma-Aldrich), anti-HA (1  g/ml; Covance),
anti-K18 (0.4  g/ml; Santa Cruz Biotechnology, Inc.), anti-lamin A/C (0.4
 g/ml; Santa Cruz Biotechnology, Inc.), and anti-active caspase-3 (1:1,000;
Cell Signaling Technologies). Goat anti–rabbit-Ig-HRP (1:15,000; Santa
Cruz Biotechnology, Inc.) or isotype specific goat anti–mouse IgG-HRP
(1:15,000; Southern Biotechnology) were used as secondary antibodies. 
Immunofluorescence microscopy
Cells were grown on poly-prep slides (Sigma-Aldrich) and fixed with 2%
paraformaldehyde for 20 min at room temperature. After the fixation the
slides were washed three times with 50 mM NH4Cl (in PBS) for 3 min, per-
meabilized in ice-cold PBS with 0.3% Triton X-100 (Sigma-Aldrich) for 1
min, washed with PBS-Mg (PBS   1 mM MgCl2), and incubated for 10 min
in blocking solution (PBS, 0.01% saponin, 0.25% BSA and 0.02% NaN3).
The slides were incubated for 2 h at room temperature or overnight at 4 C
with the indicated antibodies: DED3 (8  g/ml), anti-K8 (5  g/ml; Sigma-
Aldrich), M30 (1:50; Roche), anti-active caspase-3–FITC (9  g/ml; Phar-
mingen), and anti-DEDD2 (10  g/ml). Peptide competition for the DED3
antibody was performed as previously described (Schickling et al., 2001).
After washing with PBS-Mg, slides were incubated with secondary antibodies
(5  g/ml; Southern Biotechnology) and DAPI (2  g/ml) for 1 h at room
temperature, washed, and dehydrated in 100% ethanol. Coverslips were
mounted onto the slides with Vectashield mounting medium (Vector Labo-
ratories) and analyzed with an Axiovert S100 immunofluorescence micro-
scope equipped with an Axiocam digital camera and software (Zeiss).
Confocal pictures were taken and analyzed with a confocal microscope
LSM 510 (Zeiss).
Intracellular FACS analysis
Cells were fixed for 30 min in methanol ( 20 C), pelleted for 5 min at 500 g,
and blocked for 30 min at room temperature in incubation buffer (PBS,
0.1% Tween 20, and 1% BSA). Primary antibodies were diluted in incuba-
tion buffer (DED3 10  g/ml, M30 1:50, anti-CD8 10  g/ml [Pharmingen],
anti-active caspase-3–FITC 1:10) and incubated with the cells for 1 h at
room temperature. Subsequently, the cells were washed with washing
buffer (PBS, 0.1% Tween 20) and incubated with FITC-conjugated second-
ary antibodies (10  g/ml; Southern Biotechnology) for 30 min at room
temperature. The cells were washed twice and analyzed by fluorescence-
activated cell sorter (FACScan; Becton Dickinson).
Electron microscopy and immunogold cytochemistry
Cells were fixed with a mixture of 4% formaldehyde and 0.1% glutaralde-
hyde in Dulbecco’s PBS, pH 7.4, for 1 h at room temperature, spun down
in a swing-out rotor at 3,000 g, rinsed in PBS, dehydrated in ethanol, and
infiltrated with Unicryl resin from British Biocell International Ltd. The
resin was polymerized with UV radiation (360 nm), at 4 C, according to
the manufacturer’s instructions. Ultrathin sections were blocked with nor-
mal goat serum, diluted 1:50 in PBS containing 1% BSA and 1% Tween
20, for 4 h at room temperature. Serial sections were incubated, for 18 h at
4 C, with antibodies to DEDD (DED3),  -actin, tubulin, vimentin, cytoker-
Figure 10. Model of DEDD function during 
apoptosis. In nonapoptosing cells, certain amounts 
of DEDD (likely in its diubiquitinated form) are 
constitutively associated with the K8/K18 network 
and/or procaspase-3. Upon induction of apoptosis 
by a variety of agents, early during apoptosis a 
small amount caspase-3 is activated (step I) likely 
involving mitochondria (not depicted). This 
population of caspase-3, via unknown mechanisms, 
aids directly or indirectly in the aggregation of 
DEDD. Apoptotic DEDD then concentrates cas-
pase-3 at the K8/18 network leading to the 
activation of caspase-3. At this stage all three 
molecules are visualized as filamentous structures 
(step III). After disintegration of the filaments (step IV), 
intracytoplasmic proteinaceous inclusions are 
formed that also contain DEDD, DEDD2, active 
caspase-3, and IF proteins. These structures are 
later found in apoptotic cytoplasmic blebs (step V). DEDD regulates caspase cleavage of cytokeratins | Lee et al. 1065
atins 8 and 18, and to the caspase-3 cleavage fragment of cytokeratin 18
(M30). These primary antibodies were all diluted (1   5) in PBS containing
1% normal goat serum, 1% BSA and 1% Tween 20 (PBSGAT). In control
incubations, the primary antibodies were replaced with mouse IgG1 or
normal rabbit serum (Dako Ltd.). Thorough washing in PBSGAT was fol-
lowed by incubation, for 18 h at 4 C, in the appropriate goat-derived anti–
mouse or –rabbit IgG (British Biocell International Ltd.). Secondary anti-
bodies, adsorbed against human serum proteins and conjugated with 10
nm colloidal gold, were diluted 1:50 in PBSGAT. Sections incubated with
mixtures of mouse- and rabbit-derived antibodies were subsequently la-
beled with a mixture of anti–mouse antibody conjugated with 10 nm gold
and anti–rabbit antibody conjugated with 5 nm gold, respectively. Ul-
trathin sections were examined unstained or after staining with lead citrate
and/or uranyl acetate.
Ubiquitination of DEDD
293T cells were transiently cotransfected by the calcium-precipitation
method as previously described (Stegh et al., 1998) with DEDD-FLAG or
DEDD NLS-FLAG in the presence of vector or pMT123 at the indicated
amounts. Cells were harvested 24 h after transfection, lysed in sample
buffer, and Western blots were probed with anti-FLAG. For IP, cells were
lysed with 2% empigen (as described in Lowthert et al., 1995). Lysates
were spun down and incubated with 10  g anti-FADD 1C4 or anti-FLAG
M2 (Sigma-Aldrich) and 50  l of anti–mouse IgG1 beads (Sigma-Aldrich)
at 4 C for 1 h rotating end to end. Beads were washed, resuspended in
sample buffer, and Western blots were probed with anti-FLAG and HA.11
(Covance). 293T cells transiently transfected with vector or pMT123 were
cultured for 4 h and treated with DMSO or 20  M MG132 (Calbiochem)
for 12 h. Cells were harvested, lysed in sample buffer, and Western blots
were probed with PRO29. E36 and ts20 cells were maintained at the per-
missive temperature (30 C) or shifted to the restrictive temperature (40 C)
for 12 h. Cells were harvested, lysed in sample buffer, and Western blots
were probed with PRO29.
Characterization of DEDD in murine tissue
A piece of tissue (size dependent on organ) from C3H or Nit   C57BL/
6Jx129 mice (one female and one male each) was diced finely with a scal-
pel and put in 200–500  l of lysis buffer (30 mM Tris, pH 7.5; 10% glyc-
erol; 150 mM NaCl; 1% NP-40) plus inhibitors and incubated on ice for 30
min to 1 h before a brief sonication. Lysates were spun at 13,000 rpm for 7
min and the supernatant transferred to a new tube. 60  g of protein were
loaded per lane for Western blotting with PRO29. 
Subcellular fractionation
Cells were harvested and lysed in ice-cold total lysis buffer composed of
250 mM NaCl; 50 mM HEPES, pH 7.0; 5 mM EDTA; 1% NP-40, Com-
plete
® protease inhibitors (Roche Molecular Biochemicals) for 60 min and
sonicated (30 s, 20% intensity). Insoluble material was pelleted with
20,000 g for 15 min at 4 C. Supernatant (S) and pellet (P) were separated
and resuspended in reducing sample buffer containing 5 M urea.
Immunoprecipitation of keratin 18 and caspase-3
HeLa cells were treated with 400  M of etoposide, harvested, and lysed
with 2% empigen lysis buffer as described previously (Lowthert et al.,
1995). Lysates were spun (14,000 rpm, 15 min) and protein amount was
quantified (Bio-Rad Laboratories). 3 mg of protein were incubated with 18
 g of anti-K18 (Santa Cruz Biotechnology, Inc.) or anti-FADD 1C4 at 4 C
1 h rotating end to end. Subsequently, 50  l of resuspended anti–mouse
IgG1-agarose beads (Sigma-Aldrich) were added to the lysate/antibody
tubes and incubated overnight at 4 C rotating end to end. Following incu-
bation, beads were washed four times with lysis buffer and resuspended in
sample buffer. MCF7-C3 cells were lysed in 1% NP-40 lysis buffer (250
mM NaCl; 50 mM Hepes, pH 7.0; 5 mM EDTA; 1% Nonidet P-40, Com-
plete
®) for 1 h on ice. Lysates were (14,000 rpm, 15 min) and protein
amount was quantified (Bio-Rad Laboratories). 3 mg of protein were incu-
bated with 10  g of anti–caspase-3 (Cell Signaling Technologies) or nor-
mal rabbit Ig (Santa Cruz Biotechnology, Inc.) at 4 C 1 h rotating end to
end. Subsequently, 35  l of resuspended protein A-Sepharose beads
(Sigma-Aldrich) were added to the lysate/antibody tubes and incubated
overnight at 4 C rotating end to end. After incubation, beads were washed
four times with lysis buffer and resuspended in sample buffer.
RNAi and cytotoxicity assay
RNAi experiments were performed as previously described (Elbashir et al.,
2001). Briefly, HeLa cells were transfected with DEDD, lamin A/C, or Cy3-
luciferase siRNAs (Dharmacon) at the indicated amounts with Transit-TKO
(Mirus) in 24-well plates according to manufacturer’s instructions and in-
cubated for 48 h. Cells were harvested and lysed in sample buffer for
Western blotting or quantified for DNA fragmentation as previously de-
scribed (Stegh et al., 1998).
Influence of DEDDDNLS on keratin 18 cleavage
293T or HeLa cells were transfected with the indicated amount of plasmid
DNA either using the calcium-phosphate (293T) or Superfect
TM (HeLa) fol-
lowing the manufacturer’s protocol (QIAGEN). 24 h after transfection the
cells were harvested and either intracellularly stained for cleaved keratin
with M30 or lysed for quantification of caspase-3 and -8 activities with flu-
orogenic caspase substrates as previously described (Stegh et al., 2000).
Online supplemental material
Video 1 is available online at http://www.jcb.org/cgi/content/full/
jcb.200112124/DC1. The three-dimensional image represented as a
QuickTime video is taken from Fig. 8 (second row, right), and shows GFP-
positive structures (green) aligning on intermediate filament strands (red)
stained with anti-K8 after treating HeLa cells transfected with caspase-3–
GFP with staurosporine for 2 h.
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